Metastatic Cancer-Induced Bone Pain: Pathophysiology and Treatment
DOI:
https://doi.org/10.51481/amc.v46i1.128Keywords:
Dolor, metastásico, óseo, revisiónAbstract
Sixty to 84% of cancer patients develop bone metastases. Of this 79% have difficult to treat bone pain syndromes, of which 50% die without adequate pain control. It is necessary to have accessible and effective drugs in the market to improve the quality of life in these patients.
The objective of this paper is to review the pathophysiology of bone pain and the drugs used today in the palliation of bone cancer pain. In addition a 6 step algorithmic approach is given to help the physicians engaged in the management of this condition.
Downloads
References
Payne R. Mechanisms and management of bone pain. American Cancer Society. Magazine supplement: Skeletal complications of malignancy 1997; 80: 16081613.
Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA et. al. Pain and its treatment in outpatients with metastasic cancer. N Engl J Med 1994; 6: 592596.
Honore P, Luger N, Sabino M, Schwei MJ, Rogers S, Mach D, et. al. Osteoprotegerin blocks bone cancerinduced skeletal pain and painrelated neurochemical changes in spinal cord. Nature 2000; 5: 521528.
Regan J, Peng P. Neurophysiology of cancer pain. Cancer Control magazine 2000; 7: 111119
OMS. Palliation of bone pain in cancer: Facts and controversies report 2002; 15: 46.
Goltzman D. Mechanism of the Development of Osteoblastic Metastases. Magazine Supplement: Skeletal Complications of Malignancy. Cancer 1997; 80: 15811587
Markman M. Clinical Trials in Oncology. En: Markman M. ed. Basic Cancer Medicine. Philadelphia: W. B. Saunders, 1997: 1113
Sabino M, Ghilardi J, Feia K. The involment of prostaglandins in tumorogenesis, tumor induced osteolysis and bone cancer pain. J Musc skel Neur Interact 2002; 2: 562561.
Meyer R, Campbell J, Raja S. Peripheral neural mechanisms of nociception. En: Wall P, Melzack R. ed. Textbook of pain. Londres: Churchil Livingstone, 1994: 1314.
Fontana A, Delmas P. Markers of bone turnover in bone metastases. Magazine Supplement: Skeletal Complications of malignancy. Cancer 2000; 88: 29522960
Raja S, Meyer J, Meyer R. Peripheral mechanism of somatic pain. Anestesiology 1988; 68: 571590.
Schimdt R, Scable H, Messlinger K, Heppelmann B, Hanesh U, Pawlak M. Silent and active nociceptors: Structure, functions and clinical implications. En: Gebhart G, Hammond D, Jensen T. eds. Progress in pain research and management. Seattle: IASP press, 1994; 2: 213250.
Niv D, Devor M. Analgesia preventiva: Se puede prevenir el dolor posoperatorio agudo? En: Abrahms B, Benzon H, Hanh M, Heaver J, Niv D, Parris W. et. al. eds. Tratamiento Práctico del Dolor. España: Harcout Brace, 2000: 10431044.
Woolf C. Evidence of a central component of post injury pain hypersensitivity. Nature 1984; 308: 686688.
Woolf C, Thompson S. The induction and maintenance of central sensibilization is dependent on NmethylDaspartic acid receptor activation: Implications for treatment of postinjury pain hypersensitivity states. Pain magazine 1991; 44: 293299.
Niv D, Devor M. Transition from acute to chronic pain. En: Arnoff G. ed. Evaluation and treatment of Chronic Pain. Baltimore: William & Wilkins, 1998: 2745
Willis W. Hiperalgesia and allodynia. New Cork: Raven Press, 1992: 230234
Mercante S. Malignant Bone Pain: Pathophisiology and treatment. Pain magazine 1997; 69: 118.
Mauskop A, Foley K. Control of Pain. En: Harrington K. ed. Orthopedic management of methastasic bone disease. St. Louis: Mosby, 1998: 455460.
Twycross R. Measurement of pain. En: Twycross R. Ed. Pain Relief in Advanced Cancer. Londres: Churchill Livingstone, 1994: 129147.
Barnard D, McGarrity S. Cuidados paliativos. En: Abrahms B, Benzon H, Hanh M, Heaver J, Niv D, Parris W. et. al. ed. Tratamiento Práctico del Dolor. España: Harcout Brace, 2000: 881902.
Doleys D, Doherty D. Evaluación piscológica y conductual. En: Abrahms B, Benzon H, Hanh M, Heaver J, Niv D, Parris W. et. al. ed. Tratamiento Práctico del Dolor. España: Harcout Brace, 2000: 429448.
Sykes F, Johnson R, Hanks G. Difficult pain problems. En: Fallon M. O Neill B. eds. ABC of Palliative Care. Londres: BMJ Books, 1998: 67
Wizenberg M. The philosophy and economics of palliative radiotherapy for bone metastases. En; Wiess L, Gilbert H. ed. Bone Metastases. Boston: Hall, 1981: 330398.
Coia L, Hanks G, Martz K. Practice patterns of palliative care in United States. 19841985. Int J Radiat Oncol Biol Phys 1988; 14: 12611269.
Ashby M. Radiotherapy in the Palliation of Cancer. En: Patt R. Ed. Cancer Pain. Philadelphia: Lippincott Co, 1993: 235249
Stein C. The control of pain in peripheral tissues by opioids. N Eng J Med 1995; 332: 168590.
Alastair J. Wood J. Pharmacologic treatment of cancer pain. N Eng J Med 1996; 335: 11241131.
Bruera E. Anorexia, Cachexia and Nutrition. En: Fallon M. O Neill B. eds. ABC of Palliative Care. Londres: BMJ Books, 1998: 1922.
Rogers M, Gordon S, Benford H. Coxon F, Luckman S, Monkkonen J. et. al. Cellular and Molecular Mechanism of action of biphosphonates. American Cancer Society. Magazine Supplement: Skeletal Complications of Malignancy 2000; 88: 29612978.
Smith J. Oncologic Emergencies. En: Patt R. ed. Cancer Pain. Philadelphia: Lippincott Co, 1993: 527541.
Serafini A. Samarium Sm153 Lexidoram for the palliation of bone Pain Associated with Metastases. American Cancer Society. Magazine Supplement: Skeletal Complications of Malignancy 2000; 88: 29342939.
Swerdlow M. Role of Chemical neurolysis and local anesthesic infiltration. En: Swerdlow M, Ventafridda V. ed. Cancer Pain. Londres: Editorial MTP, 1987: 119122.
Hofbauer L, Neubauer A, Heufelder A. Receptor Activator of Nuclear Factor -B Ligand and Osteoprotegerin. Cancer 2001; 93: 460470.
Priest J. Metastasic Cancer Pain. En: Ramamurthy S, Rogers J. eds. Pain Management. Londres: Mosby Year Book, 1990: 5455
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
